Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Alzheimer's Disease: Detection, Prevention, and Preclinical Treatment
Guest editors: Jack C. de la Torre
Article type: Review Article
Authors: Mortamais, Mariona; b; * | Artero, Sylvainea; b | Ritchie, Karena; b; c
Affiliations: [a] Inserm, U1061, La Colombière Hospital, Montpellier, France | [b] University of Montpellier 1, Montpellier, France | [c] Faculty of Medicine, Imperial College, St Mary's Hospital, United Kingdom
Correspondence: [*] Correspondence to: Marion Mortamais, Inserm U1061, Nervous System Pathologies: Epidemiological and Clinical Research, La Colombière Hospital, 34093 Montpellier cedex 5, France. Tel.: +33 4 99 61 45 68; Fax: +33 4 99 61 45 79; E-mail: [email protected].
Abstract: There is growing evidence that vascular health plays a significant role in the etiology of clinical Alzheimer's disease (AD). Understanding the timing of vascular changes in relation to progression from cognitive impairment to AD has become of increasing importance, being both possible pre-clinical markers and potentially modifiable risk factors. White matter hyperintensities (WMH) detected in vivo with magnetic resonance imaging, are commonly used to assess cerebrovascular burden in cognitive impairment and appear to be associated with an increased risk of cognitive decline due to many causes. The present review examines specifically the association between WMH and AD and its related biomarkers. Overall, current findings across the literature suggest that WMH may predict AD at least a decade before the clinical stage of the disease, independently of biomarkers of AD pathology, thus indicating that vascular factors may constitute important targets for pre-clinical detection and intervention.
Keywords: Alzheimer's disease, biomarker, cerebrovascular disease, magnetic resonance imaging, white matter hyperintensities
DOI: 10.3233/JAD-141473
Journal: Journal of Alzheimer's Disease, vol. 42, no. s4, pp. S393-S400, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]